Back to Journals » OncoTargets and Therapy » Volume 7

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis

Total article views   HTML views PDF downloads Totals
10,237 Dovepress* 9,296+ 1,467 10,763
PubMed Central* 941 364 1,305
Totals 10,237 1,831 12,068
*Since 18 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar